PEOPLE - Stentys makes appointment:
This article was originally published in Clinica
Executive Summary
French drug-eluting stent developer Stentys has appointed Hikmat Hojeibane as chief technology officer. Mr Hojeibane, who has more than 20 years' experience in the industry, joins the Paris-based firm from Johnson & Johnson. There, he held several technical leadership positions, including director of technology assessments (Ethicon), director of R&D (Cardiovations) and engineering fellow (Cordis). He has also worked for CR Bard and B Braun Medical.